IDEAS home Printed from https://ideas.repec.org/p/hal/journl/hal-02543434.html
   My bibliography  Save this paper

Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal

Author

Listed:
  • Léa Duchesne

    (iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique - INSERM - Institut National de la Santé et de la Recherche Médicale - SU - Sorbonne Université)

  • Gilles Hejblum

    (iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique - INSERM - Institut National de la Santé et de la Recherche Médicale - SU - Sorbonne Université)

  • Ndèye Coumba Toure Kane

    (Hôpital Aristide-Le-Dantec)

  • Richard Njouom

    (Centre Pasteur du Cameroun - RIIP - Réseau International des Instituts Pasteur)

  • Toni Thomas-d'Aquin

    (CeDreS - Centre de recherche et de Diagnostic sur le Sida [Abidjan, Côte d'Ivoire] - CHU de Treichville - Centre Hospitalier Universitaire de Treichville [Abidjan, Côte d'Ivoire])

  • Raoul Moh

    (UFHB - Université Félix Houphouët-Boigny, Programme PAC-CI - ANRS France Recherche Nord & sud Sida-hiv hépatites)

  • Babacar Sylla

    (CIC - CHU Bichat - INSERM - Institut National de la Santé et de la Recherche Médicale, IMEA - Institut de médecine et d'épidémiologie appliquée [AP-HP Hôpital Bichat-Claude Bernard] - AP-HP - Hôpital Bichat - Claude Bernard [Paris] - AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP))

  • Nicolas Rouveau

    (ANRS - Agence Nationale de Recherches sur le Sida et les Hépatites Virales)

  • Alain Attia

    (CHU de Yopougon - Centre Hospitalier Universitaire de Yopougon Attié [Abidjan])

  • Karine Lacombe

    (CHU Saint-Antoine [AP-HP] - AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP) - SU - Sorbonne Université, iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique - INSERM - Institut National de la Santé et de la Recherche Médicale - SU - Sorbonne Université)

Abstract

Background: Scaling-up the access to hepatitis C virus (HCV) diagnostics for people who use injecting drugs (PWID) is essential to reduce the HCV incidence in low and middle-income countries. Methods: A decision tree model was developed to compare the cost-effectiveness of 12 strategies for diagnosing HCV in Senegal with a health sector perspective. Strategies included HCV-Ab screening and confirmation of viraemia (based on HCV-RNA or HCV core antigen detection) or only the latter step. Laboratory assays and decentralized tools (point-of-care (POC) tests and dried blood spot (DBS) samples) were included. The base-case assumed a 38.9% seroprevalence, as reported in the PWID population of Dakar. Results: Compared to the cheapest strategy (POC HCV-Ab followed by POC HCV-RNA (S5)), one strategy remained un-dominated in the base-case: POC HCV-Ab followed by venepuncture-based laboratory HCV-RNA (S3). Above a lost to follow-up testing rate of 2.3%, combining POC HCV-Ab with HCV-RNA on DBS (S4) became more cost-effective than S3. Above this threshold, a single-step POC HCV-RNA (S12) was also found un-dominated (ICER to S5=€3,297.50). S5, S12 and S4 cost €14.21, €17.03 and €36.55/screened individual. Incremental cost-effectiveness ratios (€/additional true positive case) were 2,164.82 (S12 versus S5) and 3,297.50 (S4 versus S12). Whenever HCV seroprevalence reached 55.5%, S12 became more cost-effective than S5. Moreover, S4 required a budget 2 to 2.5 times higher than S5 or S12 for diagnosing 90% of HCV-infected PWID in Dakar. Conclusion: A two-step POC-based strategy (S5) would be the most cost-effective option among those proposed in this study for diagnosing HCV in PWID in Senegal. This study illustrates how the lack of secure financing and of data on PWID in LMICs, render difficult to identify the most sustainable strategy in those countries, as well as its implementation.

Suggested Citation

  • Léa Duchesne & Gilles Hejblum & Ndèye Coumba Toure Kane & Richard Njouom & Toni Thomas-d'Aquin & Raoul Moh & Babacar Sylla & Nicolas Rouveau & Alain Attia & Karine Lacombe, 2020. "Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal," Post-Print hal-02543434, HAL.
    • Handle: RePEc:hal:journl:hal-02543434
    DOI: 10.1016/j.drugpo.2019.102613
    Note: View the original document on HAL open archive server: https://hal.science/hal-02543434
    as

    Download full text from publisher

    File URL: https://hal.science/hal-02543434/document
    Download Restriction: no
    File URL: https://libkey.io/10.1016/j.drugpo.2019.102613?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Daniëla K van Santen & Anneke S de Vos & Amy Matser & Sophie B Willemse & Karen Lindenburg & Mirjam E E Kretzschmar & Maria Prins & G Ardine de Wit, 2016. "Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-18, October.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Léa Duchesne & Gilles Hejblum & Richard Njouom & Coumba Touré Kane & Thomas d’Aquin Toni & Raoul Moh & Babacar Sylla & Nicolas Rouveau & Alain Attia & Karine Lacombe, 2020. "Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-18, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Yin Liu & Hui Zhang & Lei Zhang & Xia Zou & Li Ling, 2020. "Economic Evaluation of Hepatitis C Treatment Extension to Acute Infection and Early-Stage Fibrosis Among Patients Who Inject Drugs in Developing Countries: A Case of China," IJERPH, MDPI, vol. 17(3), pages 1-13, January.
    2. Stephanie Popping & Sebastiaan J Hullegie & Anne Boerekamps & Bart J A Rijnders & Robert J de Knegt & Jürgen K Rockstroh & Annelies Verbon & Charles A B Boucher & Brooke E Nichols & David A M C van de, 2019. "Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men," PLOS ONE, Public Library of Science, vol. 14(1), pages 1-15, January.
    3. Anita W M Suijkerbuijk & Albert Jan van Hoek & Jelle Koopsen & Robert A de Man & Marie-Josee J Mangen & Hester E de Melker & Johan J Polder & G Ardine de Wit & Irene K Veldhuijzen, 2018. "Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country," PLOS ONE, Public Library of Science, vol. 13(11), pages 1-16, November.
    4. Ru Han & Clément François & Mondher Toumi, 2021. "Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results," Applied Health Economics and Health Policy, Springer, vol. 19(1), pages 29-44, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-02543434. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.